Journal article · 2021 · Open access
CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification
Journal of Clinical Investigation, 131(8) · Published 25 February 2021 · DOI 10.1172/jci141677
In brief
“CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification” is a 2021 journal article by Afam A. Okoye and 23 co-authors, published in Journal of Clinical Investigation. OpenAlex counts 43 citations as of 19 November 2026. It is open access: the full text is free to read at Journal of Clinical Investigation.
- Citations
- 43
- Most cited in
- 2023 (10)
- Field-weighted impact
- 2.27
- References
- 46
- Authors
- 24
Abstract
To define the contribution of CD8+ T cell responses to control of SIV reactivation during and following antiretroviral therapy (ART), we determined the effect of long-term CD8+ T cell depletion using a rhesusized anti-CD8β monoclonal antibody on barcoded SIVmac239 dynamics on stable ART and after ART cessation in rhesus macaques (RMs). Among the RMs with full CD8+ T cell depletion in both blood and tissue, there were no significant differences in the frequency of viral blips in plasma, the number of SIV RNA+ cells and the average number of RNA copies/infected cell in tissue, and levels of cell-associated SIV RNA and DNA in blood and tissue relative to control-treated RMs during ART. Upon ART cessation, both CD8+ T cell-depleted and control RMs rebounded in fewer than 12 days, with no difference in the time to viral rebound or in either the number or growth rate of rebounding SIVmac239M barcode clonotypes. However, effectively CD8+ T cell-depleted RMs showed a stable, approximately 2-log increase in post-ART plasma viremia relative to controls. These results indicate that while potent antiviral CD8+ T cell responses can develop during ART-suppressed SIV infection, these responses effectively intercept post-ART SIV rebound only after systemic viral replication, too late to limit reactivation frequency or the early spread of reactivating SIV reservoirs.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Okoye, A. A., Duell, D. M., Fukazawa, Y., Varco-Merth, B. D., Marenco, A., Behrens, H., Chaunzwa, M., Selseth, A. N., Gilbride, R. M., Shao, J., Edlefsen, P. T., Geleziunas, R., Pinkevych, M., Davenport, M. P., Busman‐Sahay, K., Nekorchuk, M. D., Park, H., Smedley, J. V., Axthelm, M. K., . . . Picker, L. J. (2021). CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification. Journal of Clinical Investigation, 131(8). https://doi.org/10.1172/jci141677
MLA 9
Okoye, Afam A., et al. “CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification.” Journal of Clinical Investigation, vol. 131, no. 8, 2021. https://doi.org/10.1172/jci141677.
Chicago
Okoye, Afam A., Derick M. Duell, Yoshinori Fukazawa, Benjamin D. Varco-Merth, Alejandra Marenco, Hannah Behrens, Morgan Chaunzwa, et al. 2021. “CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification.” Journal of Clinical Investigation 131 (8). https://doi.org/10.1172/jci141677.
Harvard
Okoye, A. A. et al. (2021) ‘CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification’, Journal of Clinical Investigation, 131(8). doi:10.1172/jci141677.
IEEE
A. A. Okoye et al., “CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification,” Journal of Clinical Investigation, vol. 131, no. 8, 2021, doi: 10.1172/jci141677.
BibTeX
@article{okoye2021cells,
title = {{CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification}},
author = {Okoye, Afam A. and Duell, Derick M. and Fukazawa, Yoshinori and Varco-Merth, Benjamin D. and Marenco, Alejandra and Behrens, Hannah and Chaunzwa, Morgan and Selseth, Andrea N. and Gilbride, Roxanne M. and Shao, Jason and Edlefsen, Paul T. and Geleziunas, Romas and Pinkevych, Mykola and Davenport, Miles P. and Busman‐Sahay, Kathleen and Nekorchuk, Michael D. and Park, Haesun and Smedley, Jeremy V and Axthelm, Michael K. and Estes, Jacob D. and Hansen, Scott G. and Keele, Brandon F. and Lifson, Jeffery D. and Picker, Louis J.},
journal = {Journal of Clinical Investigation},
year = {2021},
volume = {131},
number = {8},
doi = {10.1172/jci141677},
url = {https://doi.org/10.1172/jci141677}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2021 | 1 | |
| 2022 | 8 | |
| 2023 | 10 | |
| 2024 | 5 | |
| 2025 | 9 | |
| 2026 | 10 |
Its field-weighted citation impact is 2.27: it has been cited 2.27 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- CD8+ T cells
- antiretroviral therapy withdrawal
- viral rebound
- SIVmac239
- rhesus monkeys
- viral reservoir
- viral blips
- viral replication
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Okoye, A. A., Duell, D. M., Fukazawa, Y., Varco-Merth, B. D., Marenco, A., Behrens, H., Chaunzwa, M., Selseth, A. N., Gilbride, R. M., Shao, J., Edlefsen, P. T., Geleziunas, R., Pinkevych, M., Davenport, M. P., Busman‐Sahay, K., Nekorchuk, M. D., Park, H., Smedley, J. V., Axthelm, M. K., . . . Picker, L. J. (2021). CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification. Journal of Clinical Investigation, 131(8). https://doi.org/10.1172/jci141677
How many times has this paper been cited?
43 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Journal of Clinical Investigation: sign in and open the PDF from this page.
Who wrote this paper?
Afam A. Okoye, Derick M. Duell, Yoshinori Fukazawa, Benjamin D. Varco-Merth, Alejandra Marenco, Hannah Behrens, Morgan Chaunzwa, Andrea N. Selseth, Roxanne M. Gilbride, Jason Shao, Paul T. Edlefsen, Romas Geleziunas and 12 more.
What is the DOI of this paper?
10.1172/jci141677, permanently at https://doi.org/10.1172/jci141677. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.